Impetus Digital

JANUARY 3, 2023

A couple of years ago, I first wrote about how social media’s role in the Pharma and healthcare sectors has been growing exponentially. Healthcare Provider (HCP) Marketing. In the same vein, patient advocates and influencers might share their personal journeys and help raise awareness of their condition and healthcare needs.

Media 52

Media Healthcare Healthcare Recruitment 52

Healthcare Success

MAY 3, 2021

In some instances, the off-course message is about healthcare. Experienced marketing professionals and healthcare communicators recognize and avoid this classic mistake. Older Americans—sometimes labeled as Baby Boomers or (perilously as) Senior Citizens—are a vital target audience for healthcare marketing. Is 50 a senior age?

Distribution 90

Distribution Marketing Healthcare Healthcare 90

Spotio

FEBRUARY 21, 2023

The move from fee-for-service to value-based reimbursement is a sea change for the healthcare industry. The goals are to increase quality, decrease costs and turn health care into a competitive marketplace. They cite a 24% increase in drug costs per hospital admission in 2014 and a 12% increase in 2015.

Medical sales 52

Medical sales Medical Sales Physicians 52

Clarify Health

AUGUST 22, 2023

Today’s healthcare consumers are seeking a different kind of healthcare experience. Patients want more control over their healthcare choices and transparency into the cost and quality of services they receive. Alternative payment models were introduced as part of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).

Healthcare 52

Healthcare Healthcare Patients Physicians 52

MedCepts

NOVEMBER 7, 2017

We have put together the top 5 tips and benefits of social networking for those in the medical and healthcare industry. And along came some competition – facebook, twitter, google+, linkedin…. In 2015, we performed a case study of the Impact of Social Media on website rankings. Build Your Brand.

Networking 52

Networking Healthcare Healthcare Medical 52

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. The biosimilar market in the US may progress differently this time.

Competition 59

Competition Marketing FDA Physicians 59

Clarivate

JUNE 23, 2022

Analyzing historical trends for the past 10 years reveals that the number of Indian paragraph IV filers continues to grow, while the number of filers in the United States has been stable since 2015. While Mainland China has only been involved in paragraph IV filings since 2015, this volume is increasing significantly.

Distribution 52

Distribution Marketing Competition Medicine 52

Clarify Health

MARCH 27, 2023

” Niall Brennan Chief Privacy and Analytics Officer, Head of The Clarify Health Institute Raw price transparency data contains trillions of records, is inconsistently formatted, includes gaps in reporting, and paints a convoluted picture of healthcare pricing in the commercial market today.

Engineering 52

Engineering Healthcare Healthcare Marketing 52

European Pharmaceutical Review

AUGUST 23, 2022

border healthcare, specifically by repealing Article 15, which originally laid down the modalities and principles for co-operation between Member States in assessing new health technologies. governmental healthcare organisations. Vincenzo Salvatore is of counsel and leader of the Healthcare and Life Sciences Focus Team at BonelliErede.

Consulting 93

Consulting Medical Healthcare Healthcare 93

PM360

MAY 15, 2023

For example, starting in 2015 at Ogilvy, I watched companies that had been using print materials in doctors’ offices begin switching to large electronic tablets in waiting and exams rooms that displayed information for multiple brands. This is a synthesis of the growing research applying nudges in healthcare.

Marketing 52

Marketing Electronics Doctors Physicians 52

Healthcare Success

JUNE 13, 2022

More companies are making high-quality healthcare easier to access and more affordable by embracing data and technology. While healthcare has historically been among the slowest to accept new technologies, the pandemic has sped adoption. What is personalized healthcare, and how can you incorporate it into your marketing strategy?

Healthcare 98

Healthcare Healthcare Marketing Patients 98

World of DTC Marketing

JUNE 13, 2022

Sixty percent of employees in a recent survey reported experiencing healthcare cost increases that outpaced inflation in the past three years, and 63 percent expect that trend to continue, signaling potential cost challenges in the future. Right now, annual raises are being neutralized by increasing healthcare insurance premiums.

Insurance 201

Insurance Healthcare Healthcare Consulting 201

CloserIQ

OCTOBER 10, 2018

Founded 2015. Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. 6 River Systems. 51-100 employees. $46

Sales 76

Sales Management Education Marketing 76

Evolve Your Success

MAY 23, 2023

With VR simulations, sales reps can now hone their skills in lifelike scenarios, giving them a competitive edge in the field. But VR’s potential doesn’t stop there; it’s poised to revolutionize everything from healthcare to education. I landed this competitive scholarship at the National Cancer Institute at school.

Training 52

Training Medical Sales Medical sales 52

Pharmaceutical Technology

SEPTEMBER 26, 2022

Strong competition limits Sandoz's growth. Sandoz has faced and may in the future face strong competition from other generic and biosimilar pharmaceutical companies, which aggressively compete for market share, including through significant price competition. stake in their consumer healthcare joint venture for $13bn.

Competition 64

Competition Manufacturing Marketing Distribution 64

PM360

AUGUST 9, 2022

Then between 2005-2015, there were 110 global blockbuster launches, with a high concentration in specialty care and biologics. With these launches came more complex science, which pushed biopharma’s evolution to integrate more medical engagement alongside the existing commercial focus for healthcare providers and payers.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. These issues will be explored in the final article of this series.

FDA 82

FDA Healthcare Healthcare Medicine 82

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The lengthy validation of defossilised organic chemicals and plastics for the healthcare sector will take several years. The path to real zero.

Manufacturing 71

Manufacturing Pharmaceutical Healthcare Healthcare 71

MedCepts

NOVEMBER 7, 2017

Unique, relevant and quality content will provide the medical and healthcare related business a competitive edge. The image above reflects nearly 3,000 retweets and favorites from a single post (tweet) we did on January 20, 2015. The post Branding Medical and Healthcare Websites with Content appeared first on MedCepts.

Healthcare 52

Healthcare Healthcare Medical Distribution 52

Pharmaceutical Technology

JULY 23, 2008

“There’s a huge clinical need which has been undelivered for years,” says Gustav Ando, manager of the healthcare business development unit [HBDU] at Global Insight. Analysts predict Pfizer’s revenue stream would be slashed by 25% by 2015 if the company did not branch out into other areas.

Side effects 52

Side effects Marketing Pharmaceutical Sales 52

Pharmaceutical Technology

MAY 3, 2023

Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to allow consumers to get access to medicines. These medicines comprise about 10% of all generics approved each year.

Food and Drug Administration 98

Food and Drug Administration FDA Medicine Competition 98

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

APRIL 11, 2023

The FDA initially granted Orkambi approval in 2015 as the first medicine to treat the underlying cause of CF for individuals aged 12 or older with two copies of the F508del mutation. Health Canada previously approved Orkambi for CF patients ages two and above. This label expansion follows a similar label change in the US in September 2022.

Medicine 98

Medicine Patients Safety Prospecting 98

World of DTC Marketing

JUNE 7, 2021

AARP recently found that the average annual cost for one brand name medication used on a chronic basis was $6,604 in 2020, more than $1,500 higher than the average annual cost of therapy in 2015. Senator Amy Klobuchar has proposed the Competition and Antitrust Law Enforcement Reform Act. For the average older American taking 4.7

Pharma 187

Pharma Retail Prescription Competition 187

Pharmaceutical Technology

JANUARY 25, 2023

Uptake of mobile healthcare, wearable devices and web-based technologies meant decentralised clinical trials made up 30% of overall trials in 2021 – an increase of 9% since 2015. Virtual trials increased 50% year on year between 2020 and 2021 and evidence suggests the frontiers of the global clinical trial map are expanding.

Pharma 59

Pharma Pharmaceutical Distribution Patients 59

Pharmaceutical Technology

JANUARY 25, 2023

Uptake of mobile healthcare, wearable devices and web-based technologies meant decentralised clinical trials made up 30% of overall trials in 2021 – an increase of 9% since 2015. Virtual trials increased 50% year on year between 2020 and 2021 and evidence suggests the frontiers of the global clinical trial map are expanding.

Pharma 52

Pharma Pharmaceutical Distribution Patients 52